Global Human Vaccines Market to Reach 71.4 Billion by 2030
| BVXVDelisted Stock | USD 1.35 0.03 2.17% |
Slightly above 61% of BiondVax Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in BiondVax Pharmaceuticals suggests that many traders are alarmed regarding BiondVax Pharmaceuticals' prospects. BiondVax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BiondVax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
BiondVax |
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russias war on Ukraine will play out this year and the wars role in creating global instability means that the trouble on the inflation front is not over yet.New York, Jan. 27, 2023 -- Reportlinker.com announces the release of the report Global Human Vaccines Industry - httpswww.reportlinker.comp06049538utmsourceGNW Food a
Read at finance.yahoo.com
 |
BiondVax Pharmaceuticals Fundamental Analysis
We analyze BiondVax Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiondVax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiondVax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
BiondVax Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
BiondVax Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BiondVax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of BiondVax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing BiondVax Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
BiondVax Pharmaceuticals Related Equities
| ADTX | Aditxt | 5.56 | ||||
| GOVX | GeoVax Labs | 4.68 | ||||
| ARMP | Armata Pharmaceuticals | 4.46 | ||||
| ANTX | AN2 Therapeutics | 4.35 | ||||
| ATXI | Avenue Therapeutics | 4.30 | ||||
| CANF | Can Fite | 3.95 | ||||
| SABS | SAB Biotherapeutics | 1.95 | ||||
| SLRX | Salarius Pharmaceuticals | 0.60 | ||||
| ORMP | Oramed Pharmaceuticals | 0.42 | ||||
| MOLN | Molecular Partners | 0.19 | ||||
| PHVS | Pharvaris | 0.36 | ||||
| MLYS | Mineralys Therapeutics, | 0.39 | ||||
| MDWD | Mediwound | 0.73 | ||||
| VCNX | Vaccinex | 0.91 | ||||
| KTTA | Pasithea Therapeutics | 2.15 | ||||
| ADIL | Adial Pharmaceuticals | 2.86 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| BLRX | BioLineRx | 4.35 | ||||
| RNAZ | Transcode Therapeutics | 5.66 | ||||
| SRZN | Surrozen | 5.95 | ||||
| PEPG | PepGen | 8.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |